Kenneth Bate - 11 Jun 2025 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate
Issuer symbol
ATXS
Transactions as of
11 Jun 2025
Transactions value $
$0
Form type
4
Filing time
12 Jun 2025, 19:15:46
Previous filing
28 Feb 2025
Next filing
24 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BATE KENNETH Director C/O ASTRIA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 10TH FLOOR, BOSTON /s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate 12 Jun 2025 0001210238

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +26.6K $0.00 26.6K 11 Jun 2025 Common Stock 26.6K $5.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 11, 2025 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.